Learn More
Invitrogen™ Phospho-MEK1/MEK2 (Ser221) Recombinant Rabbit Monoclonal Antibody (MEK12S221-D3)
Rabbit Recombinant Monoclonal Antibody
$408.50 - $617.00
Specifications
Antigen | Phospho-MEK1/MEK2 (Ser221) |
---|---|
Clone | MEK12S221-D3 |
Concentration | 0.5 mg/mL |
Content And Storage | -20°C |
Applications | Flow Cytometry, Western Blot |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
PIMA528038
|
Invitrogen™
MA528038 |
200 μL |
Each for $617.00
|
|
|||||
PIMA537076
|
Invitrogen™
MA537076 |
20 μL |
Each for $408.50
|
|
|||||
Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
MEK 1 (MAP Kinase Kinase, also known as MKK) is an integral component of the MAP kinase cascade that regulates cell growth and differentiation (Ahn, 1993; Chong et al., 2003). In brain, this pathway also plays a key role in synaptic (Adams and Sweatt, 2002). Activated MEK 1 acts as a dual specificity kinase phosphorylating both a threonine and a tyrosine residue on MAP kinase (Kyriakis et al., 1991; Seger et al., 1991; Crews et al., 1992).Specifications
Phospho-MEK1/MEK2 (Ser221) | |
0.5 mg/mL | |
Flow Cytometry, Western Blot | |
Unconjugated | |
Rabbit | |
RUO | |
PBS with 0.1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4 | |
P31938, P36507, Q02750, Q63932 | |
26395, 26396, 5604, 5605 | |
A synthetic phospho-peptide corresponding to residues surrounding Ser221 of human phospho MEK1/2. | |
Antibody |
MEK12S221-D3 | |
-20°C | |
Recombinant Monoclonal | |
Liquid | |
IgG κ | |
Human, Mouse | |
MAP2K2 | |
AA589381; CFC3; CFC4; dual specificity mitogen activated protein kinase kinase 1; dual specificity mitogen-activated protein kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 2; EC 2.7.12.2; ERK activator kinase 1; ERK activator kinase 2; hypothetical protein; hypothetical protein LOC406728; kinase MEK1; MAP kinase kinase 1; MAP kinase kinase 2; MAP kinase/Erk kinase; MAP kinase/Erk kinase 1; Map2k1; Map2k2; MAPK/ERK kinase 1; MAPK/ERK kinase 2; MAPKK 1; MAPKK 2; MAPKK1; MAPKK2; MEK 1; MEK 2; Mek1; MEK-1; Mek2; MEK-2; MEKK1; mitogen activated protein kinase kinase 1; mitogen activated protein kinase kinase 2; mitogen-activated protein kinase kinase 1; mitogen-activated protein kinase kinase 2; mitogen-activated protein kinase kinase 2, p45; mitogen-activated protein kinase kinase type 2; MK2; MKK1; MKK2; MP2K1; PRKMK1; PRKMK2; protein kinase, mitogen activated, kinase 1, p45; protein kinase, mitogen activated, kinase 2, p45; protein kinase, mitogen-activated, kinase 1 (MAP kinase kinase 1); si:ch211-242m18.2; wu:fj56a12; wu:fj61b01; zgc:56557; zgc:56557 protein | |
MAP2K1, MAP2K2 | |
Primary | |
Protein A/G |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.